chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Just over 24 hours after the vaccine in my left arm, I was suddenly unable to move my thumb and index finger on that left hand. Use slowly came back over the course of the next hour. And I was then  able to move them freely again. I also get migraines, and as I was regaining use, I started to get a severe migraine. I also had tingling in the left shoulder blade at the time of the paralysis. I have had a migraine that caused partial temporary paralysis in the past, unrelated to Covid vaccines and prior to Covid pandemic.
Pt stated that she had a hard bump at the injection site that was improving when she came to the store. She told the intern that administered the vaccine that she felt the intern gave the shot too high and tried 2 x to puncture the skin and that was what caused the bump.  I advised the patient that this is a known reaction to the shingrix vaccine and can be more pronounced with dose 2.
Alopecia areata of the scalp, first noticed 04/12/21. Persists but has not worsened.
2 1/2 circle rash, near injection site, slightly raised; leg Prevnar given in with either MMR or Varivax. Rash better 24 hours later but still visible.
PAIN AT INJECTION SITE RADIATING TO ELBOW. CURRENT AND WORSENING PAIN AS OF 14 NOV 2013 (TODAY).
I had my vaccination on 03/21/2022. On 03/28/2022 I had swollen lymph nodes on right side from armpit to by breast. I have sought medical attention in which I had diagnostic testing CT scan and ultrasound on 12/2022. I have a follow up in 04/2023 for the results.
All this time, since last Wednesday, 23JUN2021, has had all these stomach cramps; Have had to have three bowel movements every day.; This is a spontaneous report from a contactable consumer (patient herself). An unspecified aged female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 23Jun2021 as single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. On an unspecified date in Jun2021 patient reported that she has three bowel movements every day and Saturday, the caller had four bowel movements. Since last wednesday 23Jun2021 patient has had all these stomach cramps. The stomach cramps you get when you have to go to the bathroom. Saturday the patient had to go to the bathroom four times. All day the patient has had stomach cramps and had to go. Then on 28Jun2021, the patient has had constant stomach cramps, finally around 11:30 the patient went to the bathroom. The patient has never had these stomach cramps before. Outcome of events was not recovered.  Information on the lot/batch number has been requested.
tingling in arm / tingling got worse.; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EE0164) via an unspecified route of administration in the left arm on 16Apr2021 at 12:00 (at the age of 16-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 07May2021 at 14:15 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, after the first shot, the patient experienced tingling in the left arm where the shot was given and she did not have this before. After the second shot, the tingling got worse. She was almost 3 weeks after the shot, but it did not go away. It got worse when she slept and when she lifted her arm. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tingling in arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
She then went for a COVID test (rapid) and the results were positive; This is a spontaneous report from a contactable consumer or other non hcp. A 50-years-old female patient (non-pregnant) received BNT162B2 (COMIRNATY, PFIZER-BIONTECH COVID-19 VACCINE, formulation; solution for injection, (Batch/Lot number was not reported) dose 1 via an unspecified route of administration, administered in left arm on 03Mar2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient experienced symptoms of covid 07Mar202 and the patient underwent lab tests and procedures which included sars-cov-2 test results positive on 09Mar2021. No treatment received for the adverse event. Outcome of the event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Follow-up (22Mar2021): This is a follow-up spontaneous report received from a contactable consumer (patient). The Pfizer Drug safety unit recently received the attached report submitted by patient and asked help to confirm the date that patient became aware of the adverse events in this report as these effects regulatory reporting timelines. This awareness date was the date patient became aware of the occurrence of the reported events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Person went to the restroom after the shot, then c/o dizziness while there.  Site of injection was swollen and warm.  BP: 150/80.  Ice Pack to site.  Person remained at the clinic for 30 minutes, then went home with decreased swelling at the injection site and lessened dizziness.
RN injected syringe into patient's left deltoid. Prior to administering the dose, the part where the syringe connects to the needle popped off and sprayed the solution out backwards away from patient. Patient did not receive any of the dose. Vaccine was readministered with a new syringe, needle, and dose. No adverse events occurred with patient afterwards during observation. Possible equipment (syringe/needle) malfunction.
Two days post vaccine, I started experiencing constant tinnitus in both ears. Never had tinnitus in the past or any ear problems.
shivers for several hours; headache; my stomach feels strange; This case was reported by a consumer via call center representative and described the occurrence of shivers in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 20th August 2020, the patient received the 2nd dose of Shingles vaccine. In August 2020, less than a week after receiving Shingles vaccine, the patient experienced headache and stomach discomfort. On 20th August 2020, the patient experienced shivers. On an unknown date, the outcome of the shivers, headache and stomach discomfort were unknown.   It was unknown if the reporter considered the shivers, headache and stomach discomfort to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient had shivers for several hours during the night, the patient a headache and stomach feels strange.
Received pneumococcal vaccine on 7-1-15. Within 4 hours arm numb extreme pain. Went to ER - sent to orthopaedic surgeon. 6+ months physical therapy. Still limited use of arm/shoulder.
Received routine immunizations (R) thigh on 2/5/18, Mother noticed swelling next day. Came to ED for viral URI on 2/19 and thigh noted to be tender and hard. Xray-> no FB or osteo, US showed hematoma, less likely abscess, worse on 3/6/18 -> ED.
Patient had anaphylaxis. About 20 to 30 minutes after her immunizations, patient complained of her 'throat closing' and chest tightness. EMS arrived and felt the patient was wheezing, so gave an Albuterol treatment and a dose of Benadryl. When the patient arrived in the ED about 20 minutes later, she no longer had chest pain or difficulty breathing. Her vitals signs were stable, on exam she was not wheezing nor had any rash. We gave her a dose of steriod and H2 blocker and observed her for 6 hours after the event. No further events occured. Patient was discharged on steroids and benadryl.
Patient woke up on 7-11-09 and her eyes were puffy both the top + bottom lids.  No itching or burning.  Eye eyes are still puffy 2 wks later.
patient called to cancel his second dose appointment reporting that 7 hours after he got his first dose he got a terrible headache and for the next 3 days his chest was pounding because his heart rate was so fast. He was about to call and make a doctors appointment if it didn't resolve but on the 3rd day it started to go back to normal. He wasn't sure how fast his heart rate was but his chest was "pounding non-stop day and night".
fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66 year-old male patient received bnt162b2 (BNT162B2), administration date 24Mar2021 (Lot number: ER8727, Expiration Date: 31Jul2021) at the age of 66 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PYREXIA (non-serious) with onset 25Mar2021, outcome "not recovered", described as "fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pyrexia. Additional information: fever began at 99.3 and that was ongoing, It was gotten higher. She took Tylenol about 2 hours before when it was 101.7. She would say the fever has worsened because it went up to 101.7.  No follow-up attempts are possible. No further information is expected.
Sx started 02/21/21 itching, red and slight rough area of skin.
This case was reported by a healthcare professional and described the occurrence of swelling of injection site in a 5-year-old female subject who was vaccinated INFANRIX (GlaxoSmithKline). Concurrent vaccinations given on 19 August 2008 included the 1st dose of FLUMIST; MedImmune; intranasal; and poliomyelitis virus vaccine; Sanofi Pasteur; unknown. Concurrent medications included TYLENOL. On 19 August 2008, the subject received the 5th dose of INFANRIX (.5 ml, unknown, left arm). At an unspecified time after vaccination with INFANRIX, the subject experienced swelling at the injection site and injection site redness. The reporter indicated that medical attention was required at the physician's office. The reporter stated that the INFANRIX vaccination series was neither discontinued, nor delayed. At the time of reporting, the outcome of the events was unspecified. Follow-up information was received on 12 September 2008 via a nurse, who reported that the onset of the events occurred on 19 August 2008, on the same day the subject received the INFANRIX vaccination. After an unspecified period of time, the events were resolved. The healthcare professional considered the events to be related to vaccination with INFANRIX, but indicated that she did not consider the events to be serious. The healthcare professional also indicated that the INFANRIX vaccination series was neither discontinued, nor delayed.
Pain on injection site; This is a spontaneous report from a contactable consumer (patient). A 47-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization.  Medical history type 1 diabetes. The patient's concomitant medications were not reported.  The patient experienced pain on injection site 18 hours following first dose of BNT162b2 COVID-19 vaccine.  The outcome was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Case number PHEH2014US001723, is a combined initial and follow up spontaneous report received from the nurse on 20 Jan 2014 and 21 Jan 2014. This report refers to a 21-year-old pregnant female. Her medical history and concomitant medications was not reported. She was vaccinated with FLUVIRIN (batch number: not reported) intramuscularly on 29 Oct 2013. It was reported that she did not know that she was 5 weeks pregnant at the time of vaccination. It was reported that the hospital threatened her job if she did not get vaccinated. On an unspecified date one week after vaccination, she started bleeding. The doctor at the emergency room could not determine the cause of bleeding. The baby had a heart rate of 152 beats/min on 12 Nov 2013. She had a miscarriage on 13 Nov 2013. She was 5.5 weeks pregnant at the time of miscarriage. The seriousness and causality was not reported.
Pt took (HPV #1) 1 year ago 10-24-11. On 11-4-12 she went to her pediatrician with c/o severe leg pain & muscle aches.
Exactly 7 days after the 1st injection, I woke up and noticed my left arm was itchy near the injection site.  All previous soreness had resolved from the injection so was surprised to have the itching.  As the day progressed I noticed increased inflammation and redness. A small  red circle around the injection site and a larger swelling just below.  Maybe about 2" in diameter.
Initial flu vaccine injection was uneventful. Severe right upper arm pain about 5 1/2 hrs post injection; Rated pain 5 on 1-10 scale initially. Currently pain is 5 during the day and 8 at night. Severe pain at injection site. Unable to sleep at night. Appt. with PCP 10/29/14, who recommended contact of pharma. company. Right hand numbness.
Initial report was received from another manufacturer (document number 45216582), who received the report from a health care professional, who is also the patient. An adult female patient (date of birth reported as 1961) had received Pertussis vaccination (manufacturer, lot number not reported) as a child, and two years ago while in nursing school, she contracted pertussis from a patient. The patient sought medical attention which as specified as "office" and subsequently recovered from the event. No additional information was provided at the time of the report. Documents held by sender: None.
Present to ED for chest pain, nausea, chest heaviness, mild headache and slight SOB with lower extremity swelling, Hospitalized starting today 2/5. EKG shows Afib with RVR (new oneset). Still in hospital at this time
Patient states felt good that morning at work, obtained the Moderna 2nd vaccine of the series at 12:00 noon on 1/27/2021 in the Wellness clinic area as were many other employees and patients. Patient went back to work and finished shift as usual. Ate normal supper at home with husband. Very shortly after going to bed, symptoms began suddenly of significant chest pain like sharp shooting pain with shortness of breath and pressure to the front left chest which began at 10:00 pm. These symptoms continued with then nausea, vomiting and weakness. EMS was called and upon arrival at patient's home evaluation and EKG performed, O2 Saturation at 96%. It was decided for patient to treat symptoms at home to decrease risk of Covid 19 exposure in the already overtaxed Emergency Department. EMS stayed with the patient for 1 hour.  Note: Patient does have a significant family history of cardiac disease. Patient has had interittent and infrqquent episodes of chest Heart rate pauses and/or flutter, racing noted especially after form of caffeine ie) coffee
The vaccine was taken out of the refrigerator on 07-Apr-2023 at 8:20 am and administered to the patient on 10-Apr-2023 1:00 pm; no adverse event; Patient received bivalent vaccine exposed to room temperatures greater than 24 hours on 10-Apr-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received bivalent vaccine exposed to room temperatures greater than 24 hours on 10-Apr-2023), PRODUCT STORAGE ERROR (The vaccine was taken out of the refrigerator on 07-Apr-2023 at 8:20 am and administered to the patient on 10-Apr-2023 1:00 pm) and NO ADVERSE EVENT (no adverse event) in a 45-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7173B) for COVID-19 prophylaxis.   Concurrent medical conditions included Hypertension.    On 10-Apr-2023 at 1:00 PM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Apr-2023 at 1:00 PM, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received bivalent vaccine exposed to room temperatures greater than 24 hours on 10-Apr-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was taken out of the refrigerator on 07-Apr-2023 at 8:20 am and administered to the patient on 10-Apr-2023 1:00 pm). an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received bivalent vaccine exposed to room temperatures greater than 24 hours on 10-Apr-2023), PRODUCT STORAGE ERROR (The vaccine was taken out of the refrigerator on 07-Apr-2023 at 8:20 am and administered to the patient on 10-Apr-2023 1:00 pm) and NO ADVERSE EVENT (no adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received bivalent vaccine exposed to room temperatures greater than 24 hours on 10-Apr-2023) and PRODUCT STORAGE ERROR (The vaccine was taken out of the refrigerator on 07-Apr-2023 at 8:20 am and administered to the patient on 10-Apr-2023 1:00 pm).    No concomitant medications were reported.  Patient received first dose of Moderna COVID-19 vaccine monovalent on 12-Jan-2021 (lot number 25J20A), second dose on 09-Feb-2021 ((lot number 013L20A) and first booster dose on 03-Dec-2021 (lot number 037F21A).  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-719683 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-719683:same reporter
Swollen lymphnodes.  Went away by 5/15; however I did not hear of this being g a side effect and thought I should report it.
This was the patient's second dose of the Pfizer COVID19 vaccine. The patient came with her mother. She was slightly nervous before getting the vaccine. The vaccine was given to her; she was pleasantly surprised that it barely hurt and even said "wow that was nothing!". Her mother did mention that the patient got her first dose at a clinic where the pharmacist who gave it to her gave the vaccine very roughly and the patient and her mother were in tears after the FIRST shot at clinic so they were so thankful that it barely hurt for her SECOND dose. Then we started talked about traveling and everyone was engaged in a pleasant conversation for about 5 minutes. Then suddenly the patient almost fell to the side but thankfully the chair that the patient was in had armrests and her mother caught her. We gave the patient a bottle of Sprit soda for her to drink. The patient was still in her chair and resting against her mother and said "I'm fine" but her mother insisted that we call 911. So 911 was called while a pharmacy team member stayed in the room to help keep and eye on the patient. After 911 was called that patient didn't need to rest against her mother anymore but she looked very pale and looked like she wanted to throw up. Shortly after the fire department and EMS came and took over the situation. When EMS came they said it probably sounded like a vasovagal reaction. Afterwards they cleared the situation and the patient and mother were fine afterwards (patient regained color in her face and looked and sounded normal).
REALLY SICK; TWICE AS MANY SIDE EFFECTS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced really sick, and twice as many side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the really sick and twice as many side effects was not reported. This report was non-serious.
Fever; chills; dizzy; nausea; no appetite; exhausted; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 84-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FK 9893) at the age of 84 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: HYDROCHLOROTHIAZIDE; LOSARTAN; SIMVASTATIN. Vaccination history included: Covid-19 vaccine (Dose number: 1 and 2, Primary Immunization series complete but unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (Dose number: 3 (Booster), dose received: More than 3), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 13Apr2022 at 12:00, outcome "recovering", described as "Fever"; CHILLS (non-serious) with onset 13Apr2022 at 12:00, outcome "recovering"; DIZZINESS (non-serious) with onset 13Apr2022 at 12:00, outcome "recovering", described as "dizzy"; FATIGUE (non-serious) with onset 13Apr2022 at 12:00, outcome "recovering", described as "exhausted"; NAUSEA (non-serious) with onset 13Apr2022 at 12:00, outcome "recovering"; DECREASED APPETITE (non-serious) with onset 13Apr2022 at 12:00, outcome "recovering", described as "no appetite". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, chills, dizziness, nausea, decreased appetite, fatigue.  Additional Information: If other vaccine in four weeks was reported as no. If covid prior vaccination was reported as no. If covid tested post vaccination was reported as no  No follow-up attempts are possible. No further information is expected.
Severe right arm pain, migraine HA, chills, body aches, nausea, fatigue
At around 12:00 pm I noticed my fingers felt numb, then I felt very cold. I went to the bathroom and had a bowel movement but felt faint and laid on the floor. I then broke out in a cold sweat and was nauseated. After getting assistance to get off the floor I laid down for 2 hours while drinking water. I had chills and my arm was swollen. I slept very little last night. Woke up with a pulsating headache and feeling fatigued, I then went to the urgent care for further evaluation.